Degenerative Disorder of Bone Completed Phase 1 Trials for Dibotermin alfa (DB11639)

IndicationStatusPhase
DBCOND0059496 (Degenerative Disorder of Bone)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01690260Parallel Study Between BMP-2 and Autologous Bone Graft After Ilizarow TreatmentTreatment